CD274 and head and neck squamous cell carcinoma: In R/M HNSCC trials, a higher response rate and better survival in patients with high PD-L1 expression were also observed in the subgroup analysis of some ICI trials, including KEYNOTE-040 and KEYNOTE-048 [9,50,51].